We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Inhibitory Effect of (2 R)-4-(4-hydroxyphenyl)-2-butanol 2- O -β-d-apiofuranosyl-(1→6)-β-d-glucopyranoside on RANKL-Induced Osteoclast Differentiation and ROS Generation in Macrophages.
- Authors
Kim, Eun-Nam; Kim, Ga-Ram; Yu, Jae Sik; Kim, Ki Hyun; Jeong, Gil-Saeng
- Abstract
In bone homeostasis, bone loss due to excessive osteoclasts and inflammation or osteolysis in the bone formation process cause bone diseases such as osteoporosis. Suppressing the accompanying oxidative stress such as ROS in this process is an important treatment strategy for bone disease. Therefore, in this study, the effect of (2R)-4-(4-hydroxyphenyl)-2-butanol 2-O-β-d-apiofuranosyl-(1→6)-β-d-glucopyranoside (BAG), an arylbutanoid glycoside isolated from Betula platyphylla var. japonica was investigated in RANKL-induced RAW264.7 cells and LPS-stimulated MC3E3-T1 cells. BAG inhibited the activity of TRAP, an important marker of osteoclast differentiation and F-actin ring formation, which has osteospecific structure. In addition, the protein and gene levels were suppressed of integrin β3 and CCL4, which play an important role in the osteoclast-induced bone resorption and migration of osteoclasts, and inhibited the production of ROS and restored the expression of antioxidant enzymes such as SOD and CAT lost by RANKL. The inhibitory effect of BAG on osteoclast differentiation and ROS production appears to be due to the inhibition of MAPKs phosphorylation and NF-κβ translocation, which play a major role in osteoclast differentiation. In addition, BAG inhibited ROS generated by LPS and effectively restores the mineralization of lost osteoblasts, thereby showing the effect of bone formation in the inflammatory situation accompanying bone loss by excessive osteoclasts, suggesting its potential as a new natural product-derived bone disease treatment.
- Subjects
INTEGRINS; LIPOPOLYSACCHARIDES; BONE diseases; BONE resorption; BONE growth; MACROPHAGES; THERAPEUTICS
- Publication
International Journal of Molecular Sciences, 2021, Vol 22, Issue 1, p222
- ISSN
1661-6596
- Publication type
Article
- DOI
10.3390/ijms22010222